Autologous Melan-A/MART-1-specific CTL clones

Melan-A/MART-1-specific cytotoxic T lymphocytes · Nantes University Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Melan-A/MART-1-specific CTL clones, covering 2008-07-24 to 2008-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones [Phase 1, Phase 2]